Clinical trials recruiting for Atypical Endometrial Hyperplasia
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Letrozole 2.5mg | 2 |
| Diane-35 | 1 |
| GnRH antagonist | 1 |
| GnRHa | 1 |
| Levonorgestrel-Releasing Intrauterine Contraceptive System (Mirena), 52 Mg | 1 |
| MET | 1 |
| Megestrol Acetate 160 MG Oral Tablet | 1 |
Self-screener
Recruiting trials
- GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
- GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
- Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
Related conditions
Trials recruiting for Atypical Endometrial Hyperplasia often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Atypical Endometrial Hyperplasia trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.